Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $274.80 million. The enterprise value is $291.21 million.
Important Dates
The last earnings date was Tuesday, March 25, 2025, before market open.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 8.90 million shares outstanding. The number of shares has increased by 2.48% in one year.
| Current Share Class | 8.90M |
| Shares Outstanding | 8.90M |
| Shares Change (YoY) | +2.48% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 30.06% |
| Owned by Institutions (%) | 17.76% |
| Float | 3.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.02 |
| Forward PS | 2.58 |
| PB Ratio | 6.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.83.
| Current Ratio | 2.18 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.86 |
Financial Efficiency
Return on equity (ROE) is -23.74% and return on invested capital (ROIC) is -5.71%.
| Return on Equity (ROE) | -23.74% |
| Return on Assets (ROA) | -4.50% |
| Return on Invested Capital (ROIC) | -5.71% |
| Return on Capital Employed (ROCE) | -8.01% |
| Revenue Per Employee | $802,522 |
| Profits Per Employee | -$89,487 |
| Employee Count | 108 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 2.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.57% in the last 52 weeks. The beta is 1.37, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -16.57% |
| 50-Day Moving Average | 34.17 |
| 200-Day Moving Average | 32.77 |
| Relative Strength Index (RSI) | 43.63 |
| Average Volume (20 Days) | 24,516 |
Short Selling Information
The latest short interest is 164,623, so 1.85% of the outstanding shares have been sold short.
| Short Interest | 164,623 |
| Short Previous Month | 172,524 |
| Short % of Shares Out | 1.85% |
| Short % of Float | 4.48% |
| Short Ratio (days to cover) | 7.39 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $86.67 million and -$9.66 million in losses. Loss per share was -$1.14.
| Revenue | 86.67M |
| Gross Profit | 78.53M |
| Operating Income | -5.83M |
| Pretax Income | -4.89M |
| Net Income | -9.66M |
| EBITDA | -1.42M |
| EBIT | -5.83M |
| Loss Per Share | -$1.14 |
Full Income StatementBalance Sheet
The company has $15.88 million in cash and $32.29 million in debt, giving a net cash position of -$16.41 million or -$1.84 per share.
| Cash & Cash Equivalents | 15.88M |
| Total Debt | 32.29M |
| Net Cash | -16.41M |
| Net Cash Per Share | -$1.84 |
| Equity (Book Value) | 38.91M |
| Book Value Per Share | 4.50 |
| Working Capital | 18.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23,784 and capital expenditures -$205,848, giving a free cash flow of -$229,632.
| Operating Cash Flow | -23,784 |
| Capital Expenditures | -205,848 |
| Free Cash Flow | -229,632 |
| FCF Per Share | -$0.03 |
Full Cash Flow StatementMargins
Gross margin is 90.61%, with operating and profit margins of -6.73% and -11.15%.
| Gross Margin | 90.61% |
| Operating Margin | -6.73% |
| Pretax Margin | -11.44% |
| Profit Margin | -11.15% |
| EBITDA Margin | -1.63% |
| EBIT Margin | -6.73% |
| FCF Margin | n/a |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.48% |
| Shareholder Yield | -2.48% |
| Earnings Yield | -3.52% |
| FCF Yield | -0.08% |
Analyst Forecast
The average price target for Sanara MedTech is $48.50, which is 57.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $48.50 |
| Price Target Difference | 57.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 0.01:1.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.01:1 |
Scores
Sanara MedTech has an Altman Z-Score of 3.94 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.94 |
| Piotroski F-Score | 4 |